A citation-based method for searching scientific literature

Jared T Ahrendsen, Matthew Torre, David M Meredith, Jason L Hornick, David A Reardon, Patrick Y Wen, Kee K Yeo, Seth Malinowski, Keith L Ligon, Shakti Ramkissoon, Sanda Alexandrescu. Mod Pathol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
100

Epithelioid GBMs show a high percentage of BRAF V600E mutation.
Bette Kay Kleinschmidt-DeMasters, Dara L Aisner, Diane K Birks, Nicholas K Foreman. Am J Surg Pathol 2013
157
100

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy,[...]. J Clin Oncol 2016
453
100

Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.
Franck Bielle, Anna-Luisa Di Stefano, David Meyronet, Alberto Picca, Chiara Villa, Michèle Bernier, Yohann Schmitt, Marine Giry, Audrey Rousseau, Dominique Figarella-Branger,[...]. Brain Pathol 2018
17
100

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Matthew Mistry, Nataliya Zhukova, Daniele Merico, Patricia Rakopoulos, Rahul Krishnatry, Mary Shago, James Stavropoulos, Noa Alon, Jason D Pole, Peter N Ray,[...]. J Clin Oncol 2015
166
100

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
Kirsi J Granberg, Matti Annala, Birgitta Lehtinen, Juha Kesseli, Joonas Haapasalo, Pekka Ruusuvuori, Olli Yli-Harja, Tapio Visakorpi, Hannu Haapasalo, Matti Nykter,[...]. Neuro Oncol 2017
16
100

H3 K27M and EZHIP Impede H3K27-Methylation Spreading by Inhibiting Allosterically Stimulated PRC2.
Siddhant U Jain, Andrew Q Rashoff, Samuel D Krabbenhoft, Dominik Hoelper, Truman J Do, Tyler J Gibson, Stefan M Lundgren, Eliana R Bondra, Shriya Deshmukh, Ashot S Harutyunyan,[...]. Mol Cell 2020
26
100

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
100

Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.
Scott Ryall, Michal Zapotocky, Kohei Fukuoka, Liana Nobre, Ana Guerreiro Stucklin, Julie Bennett, Robert Siddaway, Christopher Li, Sanja Pajovic, Anthony Arnoldo,[...]. Cancer Cell 2020
72
100

Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Sherise D Ferguson, Shouhao Zhou, Jason T Huse, John F de Groot, Joanne Xiu, Deepa S Subramaniam, Shwetal Mehta, Zoran Gatalica, Jeffrey Swensen, Nader Sanai,[...]. J Neuropathol Exp Neurol 2018
28
100

Identification of NTRK fusions in pediatric mesenchymal tumors.
Dean Pavlick, Alexa B Schrock, Denise Malicki, Philip J Stephens, Dennis J Kuo, Hyunah Ahn, Brian Turpin, Justin M Allen, Mark Rosenzweig, Kamran Badizadegan,[...]. Pediatr Blood Cancer 2017
64
100

Mechanisms and therapeutic implications of hypermutation in gliomas.
Mehdi Touat, Yvonne Y Li, Adam N Boynton, Liam F Spurr, J Bryan Iorgulescu, Craig L Bohrson, Isidro Cortes-Ciriano, Cristina Birzu, Jack E Geduldig, Kristine Pelton,[...]. Nature 2020
130
100

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation.
David W Ellison, Cynthia Hawkins, David T W Jones, Arzu Onar-Thomas, Stefan M Pfister, Guido Reifenberger, David N Louis. Acta Neuropathol 2019
78
100

Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
Matthew Torre, Varshini Vasudevaraja, Jonathan Serrano, Michael DeLorenzo, Seth Malinowski, Anne-Florence Blandin, Melanie Pages, Azra H Ligon, Fei Dong, David M Meredith,[...]. Acta Neuropathol Commun 2020
25
100

Revisiting TP53 Mutations and Immunohistochemistry--A Comparative Study in 157 Diffuse Gliomas.
Hirokazu Takami, Akihiko Yoshida, Shintaro Fukushima, Hideyuki Arita, Yuko Matsushita, Taishi Nakamura, Makoto Ohno, Yasuji Miyakita, Soichiro Shibui, Yoshitaka Narita,[...]. Brain Pathol 2015
75
100

Clinico-pathological and molecular characterization of diffuse midline gliomas: is there a prognostic significance?
Niveditha Manjunath, Prerana Jha, Jyotsna Singh, Amol Raheja, Kavneet Kaur, Ashish Suri, Ajay Garg, Mehar Chand Sharma, Chitra Sarkar, Madan Mohan,[...]. Neurol Sci 2021
2
100

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, Felix Sahm, Andrey Korshunov, David E Reuss, Christian Koelsche, Kristin Huang, Annika K Wefers, Volker Hovestadt,[...]. Acta Neuropathol 2018
84
100


Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Mitsuaki Shirahata, Takahiro Ono, Damian Stichel, Daniel Schrimpf, David E Reuss, Felix Sahm, Christian Koelsche, Annika Wefers, Annekathrin Reinhardt, Kristin Huang,[...]. Acta Neuropathol 2018
136
100

EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression.
C Antin, A Tauziède-Espariat, M-A Debily, D Castel, J Grill, M Pagès, O Ayrault, F Chrétien, A Gareton, F Andreiuolo,[...]. Acta Neuropathol Commun 2020
6
100

Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features.
Emily A Sloan, Stephanie Hilz, Rohit Gupta, Cathryn Cadwell, Biswarathan Ramani, Jeffrey Hofmann, Cassie N Kline, Anu Banerjee, Alyssa Reddy, Nancy Ann Oberheim Bush,[...]. Acta Neuropathol 2020
4
100

Prognostic role of ALK-1 and h-TERT expression in glioblastoma multiforme: correlation with ALK gene alterations.
Dalia Elsers, Doaa F Temerik, Alia M Attia, A Hadia, Marwa T Hussien. J Pathol Transl Med 2021
2
100

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Genevieve Schindler, David Capper, Jochen Meyer, Wibke Janzarik, Heymut Omran, Christel Herold-Mende, Kirsten Schmieder, Pieter Wesseling, Christian Mawrin, Martin Hasselblatt,[...]. Acta Neuropathol 2011
655
100

Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas.
Elena Trisolini, Dounia El Wardighi, Marine Giry, Priscilla Bernardi, Renzo Luciano Boldorini, Karima Mokhtari, Marc Sanson. J Neurooncol 2019
7
100

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Kosuke Aoki, Hideo Nakamura, Hiromichi Suzuki, Keitaro Matsuo, Keisuke Kataoka, Teppei Shimamura, Kazuya Motomura, Fumiharu Ohka, Satoshi Shiina, Takashi Yamamoto,[...]. Neuro Oncol 2018
98
100

IDH2 mutation in gliomas including novel mutation.
Jaemoon Koh, Hwajin Cho, Hannah Kim, Seong Ik Kim, Sumi Yun, Chul-Kee Park, Se-Hoon Lee, Seung Hong Choi, Sung-Hye Park. Neuropathology 2015
14
100

Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.
David Castel, Thomas Kergrohen, Arnault Tauziède-Espariat, Alan Mackay, Samia Ghermaoui, Emmanuèle Lechapt, Stefan M Pfister, Christof M Kramm, Nathalie Boddaert, Thomas Blauwblomme,[...]. Acta Neuropathol 2020
21
100

Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.
Chantel Cacciotti, Jungwhan Choi, Sanda Alexandrescu, Mary Ann Zimmerman, Tabitha M Cooney, Christine Chordas, Jessica Clymer, Susan Chi, Kee Kiat Yeo. J Neurooncol 2020
8
100

Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.
A Amatu, A Sartore-Bianchi, K Bencardino, E G Pizzutilo, F Tosi, S Siena. Ann Oncol 2019
14
100


Detection of H3K27M mutation in cases of brain stem subependymoma.
Kun Yao, Zejun Duan, Yin Wang, Mingshan Zhang, Tao Fan, Bin Wu, Xueling Qi. Hum Pathol 2019
9
100

BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults.
Andrew S Chi, Tracy T Batchelor, Daniel Yang, Dora Dias-Santagata, Darrell R Borger, Leif W Ellisen, A John Iafrate, David N Louis. J Clin Oncol 2013
46
100

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
Daniel J Brat, Kenneth Aldape, Howard Colman, Eric C Holland, David N Louis, Robert B Jenkins, B K Kleinschmidt-DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp,[...]. Acta Neuropathol 2018
297
100

Pediatric ganglioglioma with an H3 K27M mutation arising from the cervical spinal cord.
Tomohiro Okuda, Nobuhiro Hata, Satoshi O Suzuki, Koji Yoshimoto, Koichi Arimura, Takeo Amemiya, Yojiro Akagi, Daisuke Kuga, Utako Oba, Yuhki Koga,[...]. Neuropathology 2018
9
100

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
Daniel J Brat, Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N Fuller, Caterina Giannini, Eric C Holland, Robert B Jenkins, Bette Kleinschmidt-DeMasters, Takashi Komori,[...]. Acta Neuropathol 2020
121
100

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas.
Gang Wu, Alberto Broniscer, Troy A McEachron, Charles Lu, Barbara S Paugh, Jared Becksfort, Chunxu Qu, Li Ding, Robert Huether, Matthew Parker,[...]. Nat Genet 2012
952
100

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
Ana S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, Michal Zapotocky, Alvaro Lassaletta, Christopher Li, Taylor Bridge, Byungjin Kim, Anthony Arnoldo, Paul E Kowalski,[...]. Nat Commun 2019
70
100

Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Patrick J Cimino, Michael Zager, Lisa McFerrin, Hans-Georg Wirsching, Hamid Bolouri, Bettina Hentschel, Andreas von Deimling, David Jones, Guido Reifenberger, Michael Weller,[...]. Acta Neuropathol Commun 2017
55
100

Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
K L Burns, K Ueki, S L Jhung, J Koh, D N Louis. J Neuropathol Exp Neurol 1998
101
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.